Results 241 to 250 of about 102,788 (290)

MicroRNA changes with macro potential contribute to secondary immunodeficiency in chronic lymphocytic leukemia during epstein barr virus reactivation. [PDF]

Sci Rep
Mertowska P, Mertowski S, Grywalska E.
europepmc   +1 more source

CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment. [PDF]

Biomolecules
Liu Y, Tang H.
europepmc   +1 more source

In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia. [PDF]

Sci Rep
Córdoba R, Bayés-Genís A, Muntañola A, Colomer D, Castro J, Leiva C, Álvarez E, Zatarain-Nicolas E.   +7 more
europepmc   +1 more source

Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia. [PDF]

Discov Oncol
Hays P.
europepmc   +1 more source

Incorrect Immunoblot in Figure.

JAMA
europepmc   +1 more source

IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers. [PDF]

Ann Hematol
Yang K, Wang Z, Xin B, Li Y, Zhao J, Sun R, Wang W, Chen D, Zhao C, Guo Y, Ma J, Wei B.   +11 more
europepmc   +1 more source

Impact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8⁺ T cells through IL-9. [PDF]

Cancer Immunol Immunother
Yang R, Zeng X, Alimu X, Qu J.
europepmc   +1 more source

Incremental immunogenicity of multiple doses of SARS‐CoV‐2 vaccination in patients with haematological malignancies

British Journal of Haematology, EarlyView.
Abi Vijenthira, Sita Bhella, Katrina Hueniken, Allison M. Wilkin, Michael Sebag, Peng Wang, Lisa K. Hicks, Annette E. Hay, Sarit Assouline, Amaris Balitsky, Graeme Fraser, Joy Mangel, Carolyn Owen, Anthony Reiman, Laurie Sehn, Heather Sutherland, Corey Arnold, Tamara Leite, Erinn McCarthy, Angela Crawley, Curtis Cooper, Marc‐Andre Langlois, C. Arianne Buchan, VIP Study Investigators   +23 more
wiley   +1 more source